AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Larson, RA Dodge, RK Szatrowski, TP Frankel, SR
Citation: Ra. Larson et al., Results of recent clinical trials in acute lymphoblastic leukemia by the cancer and leukemia group B, HEMAT BLOOD, 40, 2001, pp. 393-401

Authors: Szatrowski, TP Hensley, ML Ely, S
Citation: Tp. Szatrowski et al., Phase I trial of docetaxel (Taxotere) for patients with relapsed or refractory acute myeloid leukemia (AML), HEMAT BLOOD, 40, 2001, pp. 477-481

Authors: Hensley, ML Peterson, B Silver, RT Larson, RA Schiffer, CA Szatrowski, TP
Citation: Ml. Hensley et al., Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: Analysis of cancer and leukemia Group B 9013, J CL ONCOL, 18(6), 2000, pp. 1301-1308

Authors: Lee, EJ George, SL Caligiuri, M Szatrowski, TP Powell, BL Lemke, S Dodge, RK Smith, R Baer, M Schiffer, CA
Citation: Ej. Lee et al., Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previouslyuntreated patients 60 years of age or older with acute myeloid leukemia: Results of cancer and leukemia group B study 9420, J CL ONCOL, 17(9), 1999, pp. 2831-2839

Authors: Hensley, ML Schuchter, LM Lindley, C Meropol, NJ Cohen, GI Broder, G Gradishar, WJ Green, DM Langdon, RJ Mitchell, B Negrin, R Szatrowski, TP Thigpen, JT Von Hoff, D Wasserman, TH Winer, EP Pfister, DG
Citation: Ml. Hensley et al., American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants, J CL ONCOL, 17(10), 1999, pp. 3333-3355

Authors: Levine, EG Cirrincione, CT Szatrowski, TP Canellos, G Norton, L Henderson, IC
Citation: Eg. Levine et al., Phase II trial of topotecan in advanced breast cancer - A Cancer and Leukemia Group B study, AM J CL ONC, 22(3), 1999, pp. 218-222

Authors: Szatrowski, TP
Citation: Tp. Szatrowski, Progenitor cell transplantation for chronic myelogenous leukemia, SEMIN ONCOL, 26(1), 1999, pp. 62-66

Authors: Czuczman, MS Dodge, RK Stewart, CC Frankel, SR Davey, FR Powell, BL Szatrowski, TP Schiffer, CA Larson, RA Bloomfield, CD
Citation: Ms. Czuczman et al., Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364, BLOOD, 93(11), 1999, pp. 3931-3939

Authors: Wetzler, M Dodge, RK Mrozek, K Carroll, AJ Tantravahi, R Block, AW Pettenati, MJ Le Beau, MM Frankel, SR Stewart, CC Szatrowski, TP Schiffer, CA Larson, RA Bloomfield, CD
Citation: M. Wetzler et al., Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience, BLOOD, 93(11), 1999, pp. 3983-3993
Risultati: 1-9 |